RRx-001, A novel dinitroazetidine radiosensitizer

The ‘holy grail’ in radiation oncology is to improve the outcome of radiation therapy (RT) with a radiosensitizer—a systemic chemical/biochemical agent that additively or synergistically sensitizes tumor cells to radiation in the absence of significant toxicity. Similar to the oxygen effect, in whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Oronsky, Bryan, Scicinski, Jan, Ning, Shoucheng, Peehl, Donna, Oronsky, Arnold, Cabrales, Pedro, Bednarski, Mark, Knox, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859863/
https://www.ncbi.nlm.nih.gov/pubmed/26841903
http://dx.doi.org/10.1007/s10637-016-0326-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859863/
https://www.ncbi.nlm.nih.gov/pubmed/26841903
http://dx.doi.org/10.1007/s10637-016-0326-y

Ejemplares similares